NCT03383718View on ClinicalTrials.gov

DSE vs. FFR in SCAD and BYSTANDER Lesions

CompletedOBSERVATIONAL
Enrollment

200

Participants

Timeline

Start Date

December 1, 2014

Primary Completion Date

December 1, 2017

Study Completion Date

December 1, 2019

Conditions
Ischemic Heart Disease
Interventions
PROCEDURE

Revascularisation

Percutaneous coronary intervention or coronary artery bypass surgery

OTHER

Optimal Medical Treatment/OMT

Standard of care in stable coronary artery disease or after acute myocardial infarction.

All Listed Sponsors
collaborator

Semmelweis University Heart and Vascular Center

OTHER

lead

Bajcsy-Zsilinszky Hospital

OTHER

NCT03383718 - DSE vs. FFR in SCAD and BYSTANDER Lesions | Biotech Hunter | Biotech Hunter